Dr Francis Richard Kush, PHD | |
117 Vip Dr Ste 310, Wexford, PA 15090-6936 | |
(724) 934-3905 | |
(724) 934-3906 |
Full Name | Dr Francis Richard Kush |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 117 Vip Dr Ste 310, Wexford, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043391147 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PS005823L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Francis Richard Kush, PHD 117 Vip Dr Ste 310, Wexford, PA 15090-6936 Ph: (724) 934-3905 | Dr Francis Richard Kush, PHD 117 Vip Dr Ste 310, Wexford, PA 15090-6936 Ph: (724) 934-3905 |
News Archive
A team of researchers at the University of Georgia and Emory University will receive $1.9 million over the next five years from the National Institutes of Health to study the neurobiological mechanisms for how regular aerobic exercise may prevent drug abuse relapse.
Researchers from Ontario, Canada, recently conducted a prospective observational study to determine the SARS-CoV-2 antibody response in chronic hemodialysis patients following one vs. two doses of the BNT162b2 COVID-19 vaccine. The results were compared to health care worker controls and convalescent serum.
A novel risk assessment tool helps identify which patients undergoing total hip replacement may be at higher risk for an implant dislocation after surgery, according to a new study from researchers at NYU Langone Health and described in the Best Poster in the Adult Reconstruction Hip at the American Academy of Orthopaedic Surgeons 2018 Annual Meeting in New Orleans.
Pharmasset, Inc. today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously.
› Verified 8 days ago
Dr. Joe Martin Utay, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12045 Perry Hwy, Wexford, PA 15090 Phone: 724-940-1090 Fax: 724-940-1030 | |
Dr. Annalisa Angelica Almendras, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bradford Rd Ste 212, Wexford, PA 15090 Phone: 412-253-7109 Fax: 412-253-7109 | |
Dr. Sofia Alvarez, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 117 Vip Dr Ste 310, Wexford, PA 15090 Phone: 724-934-3905 Fax: 724-934-3906 | |
Dr. Jason Braun, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 461 Fairmont Dr, Wexford, PA 15090 Phone: 727-251-2516 | |
Dr. Kathleen Marie Kocherzat, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 117 Vip Dr, Wexford, PA 15090 Phone: 412-494-8448 | |
Andrew Nocita, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 10475 Perry Hwy, Towne Center, Ste 300, Wexford, PA 15090 Phone: 724-759-7500 Fax: 724-759-7600 |